Replies to post #225979 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

Yes quite a common challenge generally for clinical trials. I previously posted another article discussing the stats.

No comments on that so far, I guess due to preoccupation with the provisional approvals theory.

In the light of this information it seems Anavex are doing quite well in their trial recruitment progress.